CD4 and neoplasm: Study has reported that L19mTNF treatment in combination with melphalan in the WEHI‐164 tumor model reduced Treg cells and induced a long‐lasting T‐cell‐mediated immune response involving CD4+ and CD8+ T cells 177, 178.